Literature DB >> 16681459

Design and development of mechanical embolic protection devices.

Mark K Eskandari1.   

Abstract

Carotid angioplasty and stenting (CAS) is rapidly becoming an acceptable alternative to carotid endarterectomy in many patients. Much of the success of CAS is credited to advances in equipment dedicated to this minimally invasive approach. Lower profile delivery systems, tapered stent designs and most importantly, development of mechanical cerebral embolic protection devices (EPDs) have contributed to a reduction in periprocedural neurological complications that now rival results of carotid endarterectomy. Despite a lack of level one evidence in support of EPDs, a meta-analysis as well as two recent institutional reports of CAS with and without EPDs suggest a reduced stroke risk when a mechanical protection device is incorporated as part of the procedure. Since the original description by Theron and colleagues, embolic protection systems are markedly improved in ease of use and effectiveness. The three primary groups of EPDs are distal balloon occlusion, distal filtration and proximal occlusion. Although the ideal EPD has yet to materialize, this review provides insight into current design systems and the accompanying strengths and weaknesses of each.

Entities:  

Mesh:

Year:  2006        PMID: 16681459     DOI: 10.1586/17434440.3.3.387

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

Review 1.  The Angioguard embolic protection device.

Authors:  Gail M Siewiorek; Mark K Eskandari; Ender A Finol
Journal:  Expert Rev Med Devices       Date:  2008-05       Impact factor: 3.166

2.  Vascular resistance in the carotid artery: an in vitro investigation of embolic protection filters.

Authors:  Gail M Siewiorek; Mark H Wholey; Ender A Finol
Journal:  J Vasc Interv Radiol       Date:  2008-08-29       Impact factor: 3.464

3.  Carotid artery stenting: a single center "real world" experience.

Authors:  Nazmi Krasniqi; Michael Turgut; Marc Husmann; Marco Roffi; Urs Schwarz; Matthias Greutmann; Thomas F Lüscher; Beatrice Amann-Vest; Beatrice Amann; Roberto Corti
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.